This book aims to show how film can increase awareness of the plight of farmed animals without exploiting them. Much has been written on the rights of animals, be they in the wild or circuses, hunted, experimented on, used for entertainment, or slaughtered and consumed. However, there has been little that has examined in any detail the filming of farmed animals, and nothing on a declaration of rights for such animals, thus leaving them in a limbo of neglect. Stephen Marcus Finn offers a manifesto on how to foster the rights of farmed animals in filming sets out to rectify this lacuna.

The fact that all veterinarians see emergencies on a regular basis, and the increasing importance of emergency medicine and critical care in veterinary medicine, have helped make this one of the best-selling books in The Secrets Series and in veterinary medicine and critical care. Dr. Wingfield is one of the preeminent authorities in this field, and the new edition is completely revised and updated, featuring a number of new authors, with new chapters on disaster medicine and the transfusion trigger. Critical care management of dogs and cats are also covered.Over 120 chapters covering virtually every emergency condition encountered by veterinariansDr. Wingfield is one of the top authorities in veterinary emergency medicine Emergency Procedures is contained within one separate section

African animal trypanosomosis (AAT), also called nagana, is a trans-boundary disease that has had an immense impact on cattle and is ranked among the top global cattle diseases. This and tick-borne diseases have caused major obstacles to sustainable livestock-based agricultural production and food security and are important factors in underdevelopment. Due to decreasing efficacy of available drugs, widespread trypanosome resistance, and the difficulty of sustaining other control measures, there is a need for alternative sustainable strategies to reduce the impact these diseases have on livestock. Combating and Controlling Nagana and Tick-Borne Diseases in Livestock provides the latest empirical research findings on the effects of African animal trypanosomiasis (nagana) and tick-borne disease infection in livestock, their impact on farmer livelihoods, and the measures that can be undertaken to mitigate negative effects and reduce the number of infections. While highlighting topic areas such as disease history and transmission, treatments, and the economic impacts, this book is essential for farmers, animal health and animal production professionals and practitioners, non-government organizations, researchers, academicians, and students working in fields that include but are not limited to agriculture, livestock production, environmental science, veterinary medicine, veterinary pathology, and epidemiology.

This issue of Veterinary Clinics of North America: Exotic Animal Practice focuses on Therapeutics, with topics including: Metabolic scaling and other methods used to extrapolate drug dosages for exotics; Update on antiviral therapies in birds; Multiresistant bacteria in exotic animal medicine: fact or faux?; Emergency drugs and fluid therapy in exotics; Guidelines for treatment of toxicities in exotic animals; Nutraceuticals in exotic animal medicine; Pharmacokinetic/pharmacodynamics modelling of analgesic drugs; Psychoactive drugs in avian medicine; Cardiovascular drugs in avian and small mammal medicine; Gastrointestinal drugs in small mammal medicine; Update on cancer treatment in exotics; Drug delivery methods with emphasis on low stress handling while medicating exotic animal; and Compounding and extra-label use of drugs in exotic animal medicine.

Many controlled release veterinary drug delivery systems (CRVDDS) are presently in use, and recently there has been a host of new CRVDDS within veterinary medicine. The challenges of this area of drug delivery arise from the unique anatomy and physiology of the target animal, the cost constraints associated with the value of the animal being treated and the extended periods of time that delivery must be sustained for (often measured in months).

The purpose of this book is to introduce the reader to the unique opportunities and challenges of the field of CRVDDS and to explain and discuss the basic controlled release principles underlying the development of CRVDDS. Its aim is to provide an overview of many of the areas where CRVVDS have application, and to highlight the opportunities and prospects for controlled release technology in the veterinary field.

"Controlled Release Veterinary Drug Delivery" comprises chapters that provide workers in the field (and those interested in this area) with information on the design, development and assessment of a variety of CRVDDS. The book contains chapters that describe the relevant animal physiological and anatomical considerations alongside descriptions of current and emerging controlled release delivery systems for a variety of routes for drug delivery, and present overviews on the physical and chemical assessment of veterinary controlled release delivery systems.

The veterinary area is abound with opportunities for the development of controlled release drug delivery technologies. It is an area of medicine that is open to the acceptance of novel drug delivery devices, and which readily encompasses the use of novel routes of administration. It is an area of many unmet needs, most of which offer opportunities and unique challenges for the innovative formulation scientist to provide solutions. This book will provide an insight into the biological, clinical and pharmaceutical challenges that face the formulation scientist in this interesting and diverse area of research.